Statistical Calculators › Survival Analysis › Confidence Interval for a Median Survival Time
← All Calculators

Survival Analysis

Confidence Interval for a Median Survival Time

Kaplan–Meier median survival with a nonparametric Brookmeyer–Crowley confidence interval for right-censored data. Enter one follow-up time and event indicator per subject; the calculation runs entirely in your browser.

Survival Data

Use one row per subject. Event = 1 for an observed event and 0 for right censoring.

Results

Kaplan–Meier estimate and Brookmeyer–Crowley interval using the selected confidence level.
Enter survival data and click Calculate Median CI.

Methodology

The calculator first estimates the survival function with the Kaplan–Meier product-limit estimator. The median is the first time at which the estimated survival curve is at or below 0.50.

Brookmeyer–Crowley confidence interval

The confidence interval for the median is obtained by inverting a confidence band for the Kaplan–Meier survival function. This is the nonparametric approach introduced by Brookmeyer and Crowley (1982) for arbitrarily right-censored survival data.

KM estimate: Ŝ(t) = ∏tj≤t (1 − dj/Yj)

Greenwood variance of log Ŝ(t): Var{log Ŝ(t)} = ∑tj≤t dj / [Yj(Yj−dj)]

Log–log survival limits: g(Ŝ) = log(−log Ŝ), then back-transform the normal limits on g(S).

Median CI: invert the resulting survival limits at S = 0.50.

How the interval is read

References

Brookmeyer, R. & Crowley, J. (1982). A confidence interval for the median survival time. Biometrics, 38(1), 29–41. doi:10.2307/2530286.

Kaplan, E. L. & Meier, P. (1958). Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53(282), 457–481.

this method lists median-survival confidence procedures within its survival-analysis software family; the underlying nonparametric median interval used here is the Brookmeyer–Crowley method. The R survival documentation provides an independent implementation reference for Kaplan–Meier confidence limits and the log–log transformation.

Validation example: Gehan’s 6-MP group has 21 patients, 9 events, and 12 censored observations. Using the 21 time/event pairs preloaded above and a 95% log–log interval gives a median of 23 weeks, a lower 95% limit of 13 weeks, and no finite upper limit.

Clinical Trials

Real trials behind this calculation

See the analysis this calculator plans for applied to published trial results, with the estimates, confidence intervals and interpretation explained.

ONTARGET
An independent statistical analysis of ONTARGET and its companion trial TRANSCEND: Cox hazard ratios for telmisartan, ramipril and their combination, the non-inferiority…
Phase 4 · n = 31,546
ENGAGE AF-TIMI 48
Independent statistical analysis of ENGAGE AF-TIMI 48, evaluating edoxaban versus warfarin for stroke and systemic embolic events in patients with atrial fibrillation.
Phase 3 · n = 21,105
NextCOVE
Complete statistical analysis of the phase 3 NextCOVE trial comparing mRNA-1283 with mRNA-1273 for prevention of COVID-19 in participants aged 12 years…
Phase 3 · n = 13,553
TEAM
Independent statistical analysis of TEAM, the randomized phase 3 trial comparing exemestane with tamoxifen followed by exemestane in postmenopausal patients with receptor-positive…
Phase 3 · n = 9,779
DYNAGITO
Independent statistical analysis of DYNAGITO (NCT02296138), a phase 3 trial of tiotropium/olodaterol 5/5 µg versus tiotropium 5 µg for moderate to severe…
Phase 3 · n = 7,903
STRIDE
Complete statistical analysis of the STRIDE phase 3 trial of evidence-based tailored fall prevention versus usual care, including trial design, time-to-event analysis,…
Phase 3 · n = 5,451
See all 471 trials using Kaplan-Meier estimation →
Clinical Biostats